Craft

Siegfried

Stock Price

CHF1.1 K

2024-10-29

Market Capitalization

CHF4.9 B

2024-10-29

Revenue

CHF1.3 B

FY, 2025

Siegfried Summary

Company Summary

Overview
Siegfried Holding is a company that develops and manufactures drug substances and products. It offers pharmaceutical ingredients, related intermediates, and controlled substances. The company also provides the development and production of finished dosage forms, including sterile fillings.
Type
Public
Status
Active
Founded
1873
HQ
Zofingen, CH | view all locations
Website
https://www.siegfried.ch/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Andreas Casutt

    Andreas Casutt, Chairman

    • Reto Suter

      Reto Suter, Chief Financial Officer

      • Jürgen Roos

        Jürgen Roos, Chief Scientific Officer

        • Marianne Späne

          Marianne Späne, Chief Business Officer

        Operating MetricsView all

        Patients Served per Year

        40M

        FY, 2020

        LocationsView all

        13 locations detected

        • Zofingen, AG HQ

          Switzerland

          Untere Brühlstrasse 4

        • Grafton, WI

          United States

          870 Badger Cir

        • Irvine, CA

          United States

          9342 Jeronimo Road

        • Pennsville, NJ

          United States

          33 Industrial Park Rd

        • Nantong, Jiang Su Sheng

          China

          No. 5, Tongshun Road

        • Saint-Vulbas, Auvergne-Rhône-Alpes

          France

          Parc Industriel de la Plaine de l'Ain, 530 Aliee de la Luye

        and 7 others

        Siegfried Financials

        Summary Financials

        Revenue (FY, 2025)
        CHF1.3B
        Gross profit (FY, 2025)
        CHF463.5M
        Net income (FY, 2025)
        CHF168.4M
        Cash (FY, 2025)
        CHF103.1M
        EBIT (FY, 2025)
        CHF223.8M
        Enterprise value
        $5.2B

        Footer menu